• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用QIAGEN Artus EBV™ PCR分析物特异性试剂对爱泼斯坦-巴尔病毒载量检测法进行验证。

Validation of an Epstein-Barr viral load assay using the QIAGEN Artus EBV TM PCR analyte-specific reagent.

作者信息

Ahsanuddin Arshad N, Standish M Craig, Caliendo Angela M, Hill Charles E, Nolte Frederick S

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Emory University Hospital, Atlanta, GA 30322, USA.

出版信息

Am J Clin Pathol. 2008 Dec;130(6):865-9. doi: 10.1309/AJCP04IZAMPISEWQ.

DOI:10.1309/AJCP04IZAMPISEWQ
PMID:19019761
Abstract

We describe the validation of a test for the quantification of Epstein-Barr virus (EBV) DNA (viral load) using the Artus EBV TM PCR analyte-specific reagent (ASR; QIAGEN Hamburg, Hamburg, Germany). A dilution series demonstrated a limit of detection of 2.25 log(10) copies/mL (>95% positivity rate). The limit of quantification was 3.90 log(10) copies/mL based on an SD of less than 0.15. The assay was linear from 2.17 to 6.2 log(10) copies/mL. Low (3.70 log(10) copies/mL) and high (5.40 log(10) copies/mL) patient samples had coefficients of variation (CVs) of 2.0% and 1.4%, respectively. The cycle thresholds of 4 points used to generate the standard curve had CVs ranging from 0.8% to 1.6%. A comparison of 35 matched samples showed a small positive bias (0.35 log(10) copies/mL) for the Artus ASR relative to a laboratory-developed EBV viral load assay targeting the Bam H1-W region of the EBV genome.

摘要

我们描述了使用阿图斯爱泼斯坦-巴尔病毒(EBV)TM PCR分析物特异性试剂(ASR;德国汉堡QIAGEN公司)对EBV DNA(病毒载量)进行定量检测的验证情况。稀释系列显示检测限为2.25 log(10)拷贝/毫升(阳性率>95%)。基于标准差小于0.15,定量限为3.90 log(10)拷贝/毫升。该检测在2.17至6.2 log(10)拷贝/毫升范围内呈线性。低病毒载量(3.70 log(10)拷贝/毫升)和高病毒载量(5.40 log(10)拷贝/毫升)的患者样本变异系数(CV)分别为2.0%和1.4%。用于生成标准曲线的4个点的循环阈值CV范围为0.8%至1.6%。对35份匹配样本的比较显示,相对于针对EBV基因组Bam H1-W区域的实验室自行开发的EBV病毒载量检测方法,阿图斯ASR存在较小的正偏差(0.35 log(10)拷贝/毫升)。

相似文献

1
Validation of an Epstein-Barr viral load assay using the QIAGEN Artus EBV TM PCR analyte-specific reagent.使用QIAGEN Artus EBV™ PCR分析物特异性试剂对爱泼斯坦-巴尔病毒载量检测法进行验证。
Am J Clin Pathol. 2008 Dec;130(6):865-9. doi: 10.1309/AJCP04IZAMPISEWQ.
2
Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.采用不同提取方法和PCR平台评估全血中爱泼斯坦-巴尔病毒R基因定量试剂盒。
J Mol Diagn. 2008 Jan;10(1):78-84. doi: 10.2353/jmoldx.2008.070054. Epub 2007 Dec 28.
3
Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.基于LightCycler的实时PCR与半定量PCR在不同临床标本中定量检测爱泼斯坦-巴尔病毒载量的比较。
J Med Virol. 2006 May;78(5):598-607. doi: 10.1002/jmv.20581.
4
Performance characteristics of two real-time PCR assays for the quantification of Epstein-Barr virus DNA.两种用于定量检测爱泼斯坦-巴尔病毒DNA的实时聚合酶链反应检测方法的性能特征
Am J Clin Pathol. 2006 May;125(5):665-71. doi: 10.1309/ABEY-V2VK-E6DH-XAAA.
5
Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.罗氏LightCycler爱泼斯坦-巴尔病毒定量试剂在临床实验室环境中的验证
J Mol Diagn. 2006 Nov;8(5):589-97. doi: 10.2353/jmoldx.2006.050152.
6
Evaluation of a BK virus viral load assay using the QIAGEN Artus BK Virus RG PCR test.使用 QIAGEN Artus BK 病毒 RG PCR 检测评估 BK 病毒载量分析。
J Clin Virol. 2012 Jul;54(3):260-4. doi: 10.1016/j.jcv.2012.03.007. Epub 2012 Apr 10.
7
Performance of the Real-Q EBV Quantification Kit for Epstein-Barr Virus DNA Quantification in Whole Blood.用于全血中爱泼斯坦-巴尔病毒DNA定量的Real-Q EBV定量试剂盒的性能
Ann Lab Med. 2017 Mar;37(2):147-150. doi: 10.3343/alm.2017.37.2.147.
8
Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system.中枢神经系统爱泼斯坦-巴尔病毒感染中的脑脊液定量聚合酶链反应
Ann Neurol. 2002 Nov;52(5):543-8. doi: 10.1002/ana.10321.
9
Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.造血干细胞移植后监测爱泼斯坦-巴尔病毒载量以早期干预移植后淋巴细胞增生性疾病。
J Med Virol. 2008 Mar;80(3):441-54. doi: 10.1002/jmv.21096.
10
Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.多重聚合酶链反应检测外周血白细胞中爱泼斯坦-巴尔病毒、巨细胞病毒和卡波西肉瘤相关疱疹病毒感染的流行病学
J Med Virol. 2006 Dec;78(12):1635-42. doi: 10.1002/jmv.20748.

引用本文的文献

1
Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.在鼻咽癌高发地区,血浆 Epstein-Barr 病毒 DNA 阴性及其对液体活检筛查方案的影响。
Br J Cancer. 2019 Oct;121(8):690-698. doi: 10.1038/s41416-019-0575-6. Epub 2019 Sep 17.
2
Comparison of commercial extraction systems and PCR assays for quantification of Epstein-Barr virus DNA load in whole blood.比较商用提取系统和 PCR 检测法在全血中定量检测 Epstein-Barr 病毒 DNA 载量。
J Clin Microbiol. 2012 Apr;50(4):1384-9. doi: 10.1128/JCM.05593-11. Epub 2012 Jan 11.
3
Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.
使用 Epstein-Barr 病毒载量检测来诊断、监测和预防移植后淋巴组织增生性疾病。
Clin Microbiol Rev. 2010 Apr;23(2):350-66. doi: 10.1128/CMR.00006-09.